Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-02-25 @ 7:22 PM
Study NCT ID:
NCT03610516
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2018-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-01
First Submit QC Date:
None
Study First Post Date:
2018-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-13
Results First Submit QC Date:
None
Results First Post Date:
2024-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL